Toxicity evaluation of rat muscle-derived stem cells by galantamine

Tissue Engineering and Regenerative Medicine

Volumn 7, Issue 3, 2010, Pages 362-366

  Sle Kim, E ^a   Kim, Gyeong Hae ^a   Kang, Mi Lan ^a   Kang, Yun Mi ^a   Kang, Kkot Nim ^a   Lee, Jae Hyeok ^a   Min, Byoung Hyun ^a   Kim, Jae Ho ^a   Kim, Moon Suk ^a  

^a Ajou University   (South Korea)

Author keywords

Galantamine; Muscle derived stem cells; Small molecules drug; Valproic acid toxicity

Indexed keywords

CHEMICAL CONCENTRATIONS; CONTROL GROUPS; GALANTAMINE; MUSCLE-DERIVED STEM CELLS; NEUROLOGICAL DISEASE; POSITIVE CONTROL GROUP; SMALL MOLECULES; VALPROIC ACID;

CYTOLOGY; MUSCLE; RATS; STEM CELLS;

TOXICITY;

EID: 84867901051     PISSN: 17382696     EISSN: 22125469     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. MF Pittenger, AM Mackay, SC Beck, et al., Multilineage potential of adult human mesenchymal stem cells, Science, 284, 143 (1999).
2. HB Lee, G Khang, SJ Lee. Chap.41, History and commercialization trend of tissue engineering and organization each countires; In Tissue Engineering: Concepts and Application, 2nd Eds., edited by J. J. Yoo and I. Lee, pp 751 (2002).
3. SJ Greco, P Rameshwar, Recent advances and novel approaches in deriving neurons from stem cells, Mol Biosyst, 6, 324 (2010).
4. NE Sharpless, RA DePinho, How stem cells age and why this makes us grow old, Nat Rev Mol Cell Biol, 8, 703 (2007).
5. GJ Delcroix, PC Schiller, JP Benoit, et al., Adult cell therapy for brain neuronal damages and the role of tissue engineering, Biomaterials, 31, 2105 (2010).
6. I Lee, G Khang, HB Lee, Nerve regeneration by tissue engineering, Polymer Sci Tech, 10, 782 (1999).
7. A Castano, AJ Herrera, J Cano et al., Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system, J Neurochem, 70, 1584 (1998).
8. G Kögler, P Critser, T Trapp, et al., Future of cord blood for non-oncology uses, Bone Marrow Transplant, 44, 683 (2009).
9. BM Deasy, Y Li, J Huard, Tissue engineering with musclederived stem cells, Curr Opin Biotechnol, 15, 419 (2004).
10. H Peng, J Huard, Stem cells in the treatment of muscle and connective tissue diseases, Curr Opin Pharmacol, 3, 329 (2003).
11. T Sakai, Y Ling, TR Payne, et al., The use of ex vivo gene transfer based on muscle-derived stem cells for cardiovascular medicine, Trends Cardiovasc Med, 12, 115 (2002).
12. D Woodbury, J Emily, J Darwin, et al., Bone marrow stromal cells differentiate into neuronal cells for tissue engoneered nerve regeneration, J Neurosci Res, 61, 364 (2000).
13. MH Cho, JH Lee, HH Ahn, et al., Induction of neurogenesis in rat bone marrow mesenchymal stem cells using purine structure-based compounds, Mol Biosyst, 5, 609 (2009).
14. KS Kim, HH Ahn, JH Lee, et al., Tissue Engineered In Vivo Osteogenic Differentiation of Muscle-Derived Stem Cells in In situ-Forming Three-Dimensional Chitosan Scaffolds, Biomaterials, 29, 4420 (2008).
15. ES Kim, GH Kim, ML Kang, et al., Potential Induction of Rat Muscle-Derived Stem Cells to Neural like Cells by Retinoic Acid, J Tissue Eng Reg Med, DOI: 10.1002/term.328. (2010).